Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.535 USD | -1.53% |
|
+6.87% | -18.26% |
Jul. 15 | Eton Pharma Shares Rise After FDA Accepts New Drug Application for ET-400 | DJ |
Jul. 15 | Eton Pharmaceuticals Shares Surge After FDA Accepts ET-400 New Drug Application For Review | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.26% | 92.23M | |
+34.09% | 10.31B | |
+40.41% | 5.23B | |
-15.24% | 4.62B | |
+11.62% | 3.52B | |
+26.25% | 2.31B | |
-38.78% | 1.78B | |
-44.54% | 1.69B | |
-0.50% | 1.64B | |
+0.07% | 1.59B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating